LESLIE HUNT: Open Payments
NPI 1578293981 · MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,439 in 227 payments from 15 companies in 2025. Trend: 2023 $6,648 · 2024 $5,839 · 2025 $5,439
Food & beverage: $3,439Speaker / faculty: $2,000
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $2,483 |
| Axsome Therapeutics, Inc. | 22 | $506 |
| Vanda Pharmaceuticals Inc. | 19 | $490 |
| E.R. Squibb & Sons, L.L.C. | 34 | $436 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $416 |
| Teva Pharmaceuticals USA, Inc. | 19 | $261 |
| Lundbeck LLC | 20 | $242 |
| Otsuka America Pharmaceutical, Inc. | 13 | $163 |
| Alkermes, Inc. | 17 | $156 |
| Neurocrine BioSciences, Inc. | 5 | $107 |
Products named: VRAYLAR, Auvelity, COBENFY, CAPLYTA, HETLIOZ, REXULTI, AUSTEDO XR, FANAPT.
Industry payments across OH — which companies pay providers there.
